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from this study should emphasize the need for the inclussion of stratiﬁ-
cation by gender in future clinical trials. 
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Objective: To evaluate the expression and clinical signiﬁcance of cyto-
keratin subtypes (CK7,CK20) and thyroid transcription factor-1 (TTF-
1) in bronchioloalveolar carcinoma (BAC), furthermore, investigate the 
value of these factors in identiﬁcation of the prognosis of BAC.
Methods: 81 cases of surgically resected BAC specimens (including 
68 nonmucinous types and 13 mucinous types) were collected from 
The Cancer Hospital of Tianjin Medical University during the period 
from 1990 to 2000. Expression of CK7, CK20 and TTF-1 of them 
was studied by immunohistochemistry. The value of the three factors 
in identiﬁcation of the prognosis of BAC was examined by survival 
analysis. 
Results: No signiﬁcant correlation was found between CK7 positive 
rate and age-groups, clinical stages and pathological subtypes of BAC 
(P>0.05). The positive rate of CK20 was higher in stage I-II and muci-
nous types than that in stage III and nonmucinous types. The positive 
rate of TTF-1 was signiﬁcantly higher in stage III and nonmucinous 
types than that in stage I-II and mucinous types (P<0.05). There was 
a statistically signiﬁcant positive correlation between expression of 
CK7 and TTF-1 (r=0.257, P=0.021). The main prognostic factors were 
TTF-1 expression, clinical stage, tumor diameter and N stage (P<0.05). 
Strata analysis suggested that the survival time of BAC with TTF-1 
positive was superior to that with TTF-1negative in nonmucinous types 
(P=0.009); the survival time of BAC with TTF-1 positive was superior 
to that with TTF-1 negative in stage III (P=0.022). Cox Regression 
suggested that TTF-1 (P=0.035), TNM stage (P=0.000), tumor diameter 
(P=0.034), N stage (P=0.000) were independent factors affecting the 
prognosis. 
Conclusions: There is a statistically signiﬁcant positive correlation 
between expression of CK7 and TTF-1. TTF-1 and CK20 provide a 
new evidence for the molecular staging of BAC. TTF-1, TNM stage, 
tumor diameter and N stage are all independent factors affecting the 
prognosis of BAC.
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Background: Surgical resection is the most effective treatment for 
early stage non-small cell lung cancer. However, even after curative 
resection, many patients develop recurrences. Although the adjuvant 
chemotherapy has recently become the standard of therapy for radi-
cally resected early stage NSCLC, the beneﬁt is modest. Developing 
of new molecular markers could more accurately predict the treatment 
outcome. 
Purpose: We examined whether hypermethylation of tumor suppres-
sor genes DAPK, p16INK4a, APC1A, p14ARF, E-cadherin, MGMT 
and RASSF1A could predict the clinical outcome of 31 patients with 
primary NSCLC after radical surgical resection.
Materials and Methods: The methylation status of candidate genes 
was analyzed by methylation-speciﬁc PCR. Genomic DNA was puri-
ﬁed from tumor tissue and was subsequently treated with sodium 
bisulﬁte to convert unmethylated cytosine bases to uracil. To increase 
the sensitivity we have developed a nested PCR approach. A ﬁrst PCR 
ampliﬁes a larger fragment using primers, which do not discriminate 
between the methylated or wild-type genotype. The second PCR uses 
nested primers, which speciﬁcally amplify either methylated or un-
methylated sequences. Results were visualized by gel electrophoresis. 
Results: Methylation was detected at a frequency of 74.2% for DAPK, 
77.4% for p16INK4a, 74.2% for APC1A, 71.0% for p14ARF, 80.0% 
for E-cadherin, 32.3% for MGMT and 61.3% for RASSF1A. The 
univariate Cox regression model showed that methylation status of 
DAPK, p16INK4a, APC1A, p14ARF, regional lymph node status and 
gender were signiﬁcant risk factors for recurrence of NSCLC (hazards 
ratios, DAPK methylated, 55.26 [95% CI, 1.03 to 2967.62; p=0.048], 
p16INK4a methylated, 4.68 [95% CI, 1.03 to 21.34; p=0.048]; APC1A 
methylated, 0.293 [95% CI, 0.10 to 0.83; p=0.021]; p14ARF methyl-
ated, 0.312 [95% CI, 0.12 to 0.83; p=0.020]; N2, 3.59 [95% CI, 1.24 to 
10.35; p=0.018]; and male, 4.25 [95% CI, 1.22 to 14.87; p=0.023]. The 
stepwise multivariate Cox regression model identiﬁed DAPK methyla-
tion status as the only independent risk factor for recurrence.
Conclusion: Our preliminary results suggest that hypermethylation of 
DAPK could be an important factor in predicting NSCLC recurrence 
but further investigations are needed.
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Background: Bone sialoprotein(BSP) and osteopontin(OPN) have 
been demonstrated predictive of bone metastasis in breast and prostate 
carcinoma, consistent with the proposed role of BSP as a stimulator 
of bone mineralization and OPN in differentiation and activation of 
osteoclasts. Bone metastasis(BM) is often developed in non-small-cell 
lung cancer(NSCLC), but no predictive biomarkers was identiﬁed for 
high risk of metastatic bone dissemination.
Methods: 180 completely resected NSCLC patients(of 38 patients 
subsequently developed BM) were included in the investigation. Paraf-
ﬁn embedded primary tissue of these 180 patients were supplied to 
produced a tissue microarray, and investigated by immunohistochem-
istry for BSP and OPN. Different expressions of these two biomarkers 
